Balance Sheet Nasdaq, Inc.

Equities

NDAQ

US6311031081

Financial & Commodity Market Operators

Market Closed - Nasdaq Other stock markets 16:00:00 2025-06-23 EDT			5-day change	1st Jan Change
86.73 ^USD	+0.73%		+1.33%	+12.18%

06-17	Oppenheimer Adjusts Price Target on Nasdaq to $96 From $85, Maintains Outperform Rating	MT
06-11	Nasdaq To Delist Blue Star Foods	RE

c33f1ee70e7d.C5pQEu8a_sC_EtNn9auJbbWhZLUKAsbIADuba9MMNaM.eP88XoJtjLLoRYUTrJuwWsbpO4xvVKT9dQ38W7U1eetd_2dDn0y4r_c_kg

Published financial data: NASDAQ, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.63B	5.86B	6.22B	6.02B	7.36B
Other Revenues, Total	-	27M	11M	39M	36M
Total Revenues	5.63B	5.89B	6.23B	6.06B	7.4B
Cost of Goods Sold, Total	2.72B	2.47B	2.64B	2.17B	2.75B
Gross Profit	2.9B	3.42B	3.58B	3.9B	4.65B
Selling General & Admin Expenses, Total	1.36B	1.52B	1.63B	1.73B	2.03B
Depreciation & Amortization - (IS)	202M	278M	258M	323M	613M
Other Operating Expenses, Total	1.56B	1.8B	1.89B	2.06B	2.64B
Operating Income	1.34B	1.62B	1.69B	1.84B	2B
Interest Expense, Total	-101M	-125M	-129M	-284M	-414M
Interest And Investment Income	4M	1M	7M	115M	28M
Net Interest Expenses	-97M	-124M	-122M	-169M	-386M
Income (Loss) On Equity Invest.	70M	52M	31M	-7M	16M
Other Non Operating Income (Expenses)	-19M	17M	-31M	-34M	-55M
EBT, Excl. Unusual Items	1.3B	1.57B	1.57B	1.63B	1.58B
Restructuring Charges	-48M	-31M	-15M	-80M	-116M
Merger & Related Restructuring Charges	-33M	-87M	-82M	-148M	-35M
Gain (Loss) On Sale Of Investments	-	-	-	-1M	21M
Gain (Loss) On Sale Of Assets	-	84M	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-6M	-	-	-	-
EBT, Incl. Unusual Items	1.21B	1.53B	1.48B	1.4B	1.45B
Income Tax Expense	279M	347M	352M	344M	334M
Earnings From Continuing Operations	933M	1.19B	1.12B	1.06B	1.12B
Net Income to Company	933M	1.19B	1.12B	1.06B	1.12B
Minority Interest	-	-	2M	2M	2M
Net Income - (IS)	933M	1.19B	1.12B	1.06B	1.12B
Net Income to Common Incl Extra Items	933M	1.19B	1.12B	1.06B	1.12B
Net Income to Common Excl. Extra Items	933M	1.19B	1.12B	1.06B	1.12B
Per Share Items
Net EPS - Basic	1.89	2.38	2.28	2.1	1.94
Basic EPS - Continuing Operations	1.89	2.38	2.28	2.1	1.94
Basic Weighted Average Shares Outstanding	493M	498M	492M	505M	575M
Net EPS - Diluted	1.86	2.35	2.26	2.08	1.93
Diluted EPS - Continuing Operations	1.86	2.35	2.26	2.08	1.93
Diluted Weighted Average Shares Outstanding	501M	505M	498M	508M	579M
Normalized Basic EPS	1.65	1.97	2	2.02	1.72
Normalized Diluted EPS	1.62	1.94	1.98	2.01	1.71
Dividend Per Share	0.65	0.7	0.78	0.86	0.94
Payout Ratio	34.3	29.49	34.04	41.64	48.43
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.55B	1.9B	1.95B	2.16B	2.62B
EBITA	1.45B	1.79B	1.85B	2.05B	2.49B
EBIT	1.34B	1.62B	1.69B	1.84B	2B
EBITDAR	1.65B	2.01B	2.06B	2.29B	2.73B
Total Revenues (As Reported)	5.63B	5.89B	6.23B	6.06B	7.4B
Effective Tax Rate - (Ratio)	23.02	22.62	23.86	24.55	23.05
Current Domestic Taxes	164M	189M	237M	197M	236M
Current Foreign Taxes	74M	64M	77M	79M	165M
Total Current Taxes	238M	253M	314M	276M	401M
Deferred Domestic Taxes	43M	104M	42M	59M	-23M
Deferred Foreign Taxes	-2M	-10M	-4M	9M	-44M
Total Deferred Taxes	41M	94M	38M	68M	-67M
Normalized Net Income	812M	980M	984M	1.02B	989M
Non-Cash Pension Expense	23M	26M	24M	34M	54M
Supplemental Operating Expense Items
Marketing Expenses	39M	57M	51M	47M	54M
Selling and Marketing Expenses	39M	57M	51M	47M	54M
General and Administrative Expenses	424M	415M	472M	474M	542M
Net Rental Expense, Total	107M	109M	104M	129M	112M
Imputed Operating Lease Interest Expense	17.73M	17.83M	17.66M	34.81M	35.57M
Imputed Operating Lease Depreciation	89.27M	91.17M	86.34M	94.19M	76.43M
Stock-Based Comp., SG&A Exp. (Total)	5M	7M	8M	7M	9M
Stock-Based Comp., Other (Total)	82M	83M	98M	115M	132M
Total Stock-Based Compensation	87M	90M	106M	122M	141M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.74B	393M	502M	453M	592M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	20M	46M	20M	20M	13M
Total Cash And Short Term Investments	2.76B	439M	522M	473M	605M
Accounts Receivable, Total	566M	588M	677M	929M	1.02B
Total Receivables	566M	588M	677M	929M	1.02B
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	37M	29M	22M	20M	31M
Other Current Assets, Total	4.29B	6.37B	7.38B	7.67B	6.13B
Total Current Assets	7.66B	7.42B	8.6B	9.1B	7.79B
Gross Property Plant And Equipment	1.41B	1.39B	1.54B	1.64B	1.57B
Accumulated Depreciation	-557M	-514M	-559M	-662M	-606M
Net Property Plant And Equipment	856M	875M	976M	978M	968M
Long-term Investments	276M	430M	476M	467M	538M
Goodwill	6.85B	8.43B	8.1B	14.11B	13.96B
Other Intangibles, Total	2.26B	2.81B	2.58B	7.44B	6.9B
Deferred Tax Assets Long-Term	3M	2M	3M	7M	14M
Other Long-Term Assets, Total	79M	139M	129M	191M	227M
Total Assets	17.98B	20.12B	20.87B	32.29B	30.4B
Liabilities
Accounts Payable, Total	175M	185M	185M	332M	269M
Accrued Expenses, Total	451M	314M	486M	387M	644M
Short-term Borrowings	-	1.02B	664M	291M	399M
Current Portion of Leases	46M	37M	54M	62M	55M
Unearned Revenue Current, Total	235M	329M	357M	594M	711M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	4.02B	5.99B	7.09B	7.36B	5.82B
Total Current Liabilities	4.92B	7.87B	8.84B	9.02B	7.9B
Long-Term Debt	5.54B	4.81B	4.74B	10.16B	9.08B
Long-Term Leases	389M	386M	452M	417M	388M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	502M	406M	456M	1.64B	1.59B
Other Non Current Liabilities	187M	234M	226M	220M	230M
Total Liabilities	11.54B	13.71B	14.7B	21.47B	19.2B
Common Stock, Total	2M	2M	5M	6M	6M
Additional Paid In Capital	2.55B	1.95B	1.44B	5.5B	5.53B
Retained Earnings	5.63B	6.46B	7.21B	7.82B	8.4B
Treasury Stock	-376M	-437M	-515M	-587M	-647M
Comprehensive Income and Other	-1.37B	-1.59B	-1.99B	-1.92B	-2.1B
Total Common Equity	6.43B	6.4B	6.15B	10.82B	11.19B
Minority Interest	3M	10M	13M	11M	9M
Total Equity	6.44B	6.4B	6.16B	10.83B	11.2B
Total Liabilities And Equity	17.98B	20.12B	20.87B	32.29B	30.4B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	494M	493M	489M	575M	575M
ECS Total Common Shares Outstanding	495M	500M	492M	575M	575M
Book Value / Share	13	12.79	12.51	18.81	19.46
Tangible Book Value	-2.67B	-4.85B	-4.53B	-10.74B	-9.67B
Tangible Book Value Per Share	-5.4	-9.7	-9.21	-18.67	-16.82
Total Debt	5.98B	6.25B	5.9B	10.93B	9.92B
Net Debt	3.21B	5.81B	5.38B	10.46B	9.32B
Debt Equivalent of Unfunded Proj. Benefit Obligation	29M	35M	30M	27M	-
Debt Equivalent Oper. Leases	856M	872M	832M	1.03B	896M
Minority Interest, Total (Incl. Fin. Div)	3M	10M	13M	11M	9M
Equity Method Investments, Total	216M	363M	390M	380M	417M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	1.03B	1.02B	1.09B	1.24B	1.2B
Full Time Employees	4.83K	5.81K	6.38K	8.52K	9.16K
Accumulated Allowance for Doubtful Accounts (Supple)	21M	17M	15M	18M	10M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	933M	1.19B	1.12B	1.06B	1.12B
Depreciation & Amortization - CF	99M	108M	105M	117M	125M
Amortization of Goodwill and Intangible Assets - (CF)	103M	170M	153M	206M	488M
Depreciation & Amortization, Total	202M	278M	258M	323M	613M
(Gain) Loss From Sale Of Asset	-	-84M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	14M	-	-	25M	37M
(Income) Loss On Equity Investments - (CF)	-70M	-52M	-31M	7M	-16M
Stock-Based Compensation (CF)	87M	90M	106M	122M	141M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	95M	133M	80M	121M	1M
Change In Accounts Receivable	-167M	-6M	-101M	3M	-193M
Change In Accounts Payable	5M	-17M	19M	149M	-60M
Change in Unearned Revenues	15M	106M	16M	88M	67M
Change in Other Net Operating Assets	138M	-552M	234M	-201M	232M
Cash from Operations	1.25B	1.08B	1.71B	1.7B	1.94B
Capital Expenditure	-188M	-163M	-152M	-158M	-207M
Cash Acquisitions	-157M	-2.43B	-41M	-5.77B	-
Divestitures	-	190M	-	-	-
Investment in Marketable and Equity Securities, Total	141M	-31M	-2M	7M	-7M
Other Investing Activities, Total	-27M	-219M	244M	-77M	-739M
Cash from Investing	-231M	-2.65B	49M	-5.99B	-953M
Short Term Debt Issued, Total	-	420M	238M	-	-
Long-Term Debt Issued, Total	3.81B	826M	541M	5.61B	-
Total Debt Issued	3.81B	1.25B	779M	5.61B	-
Short Term Debt Repaid, Total	-391M	-	-	-371M	-291M
Long-Term Debt Repaid, Total	-1.47B	-804M	-1.1B	-260M	-521M
Total Debt Repaid	-1.86B	-804M	-1.1B	-631M	-812M
Issuance of Common Stock	50M	26M	23M	29M	-
Repurchase of Common Stock	-262M	-1B	-711M	-341M	-205M
Common Dividends Paid	-320M	-350M	-383M	-441M	-541M
Common & Preferred Stock Dividends Paid	-320M	-350M	-383M	-441M	-541M
Other Financing Activities, Total	-33M	2.3B	2.42B	-4M	-1B
Cash from Financing	1.38B	1.42B	1.04B	4.22B	-2.56B
Foreign Exchange Rate Adjustments	16M	-331M	-1.29B	202M	-537M
Net Change in Cash	2.42B	-483M	1.5B	124M	-2.11B
Supplemental Items
Cash Interest Paid	97M	118M	116M	177M	405M
Cash Income Tax Paid (Refund)	290M	501M	274M	254M	358M
Levered Free Cash Flow	922M	991M	1.39B	1.27B	1.76B
Unlevered Free Cash Flow	986M	1.07B	1.47B	1.45B	2.02B
Change In Net Working Capital	-44M	150M	-202M	-14M	-218M
Net Debt Issued / Repaid	1.95B	442M	-318M	4.98B	-812M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.27	5.33	5.17	4.33	4
Return on Total Capital	7.7	8.09	8.56	6.8	5.84
Return On Equity %	15.45	18.49	17.87	12.44	10.12
Return on Common Equity	15.46	18.51	17.93	12.48	10.15
Margin Analysis
Gross Profit Margin %	51.59	58.1	57.53	64.23	62.82
SG&A Margin	24.1	25.81	26.18	28.56	27.46
EBITDA Margin %	27.49	32.3	31.35	35.67	35.36
EBITA Margin %	25.73	30.46	29.67	33.74	33.68
EBIT Margin %	23.9	27.57	27.21	30.34	27.08
Income From Continuing Operations Margin %	16.58	20.17	18.04	17.43	15.07
Net Income Margin %	16.58	20.17	18.07	17.46	15.09
Net Avail. For Common Margin %	16.58	20.17	18.07	17.46	15.09
Normalized Net Income Margin	14.43	16.65	15.81	16.83	13.36
Levered Free Cash Flow Margin	16.39	16.84	22.36	21	23.77
Unlevered Free Cash Flow Margin	17.52	18.17	23.65	23.93	27.26
Asset Turnover
Asset Turnover	0.35	0.31	0.3	0.23	0.24
Fixed Assets Turnover	7.1	6.8	6.73	6.21	7.61
Receivables Turnover (Average Receivables)	11.39	10.15	9.83	7.5	7.55
Short Term Liquidity
Current Ratio	1.56	0.94	0.97	1.01	0.99
Quick Ratio	0.68	0.13	0.14	0.16	0.21
Operating Cash Flow to Current Liabilities	0.25	0.14	0.19	0.19	0.25
Days Sales Outstanding (Average Receivables)	32.13	35.95	37.15	48.65	48.48
Average Days Payable Outstanding	21.7	26.64	25.54	43.5	39.98
Long Term Solvency
Total Debt/Equity	92.85	97.63	95.8	100.98	88.6
Total Debt / Total Capital	48.15	49.4	48.93	50.24	46.98
LT Debt/Equity	92.14	81.16	84.15	97.72	84.54
Long-Term Debt / Total Capital	47.78	41.06	42.98	48.62	44.83
Total Liabilities / Total Assets	64.2	68.16	70.46	66.47	63.15
EBIT / Interest Expense	13.32	12.98	13.13	6.48	4.84
EBITDA / Interest Expense	16.38	16.08	15.94	8.07	6.59
(EBITDA - Capex) / Interest Expense	14.51	14.78	14.76	7.51	6.09
Total Debt / EBITDA	3.61	3.11	2.87	4.77	3.64
Net Debt / EBITDA	1.94	2.89	2.62	4.56	3.41
Total Debt / (EBITDA - Capex)	4.08	3.39	3.1	5.12	3.93
Net Debt / (EBITDA - Capex)	2.19	3.15	2.83	4.9	3.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.03	4.64	5.78	-2.6	22.03
Gross Profit, 1 Yr. Growth %	14.52	17.81	4.74	8.74	19.36
EBITDA, 1 Yr. Growth %	16.58	22.88	2.68	10.81	20.99
EBITA, 1 Yr. Growth %	16.96	23.83	3.01	10.77	21.8
EBIT, 1 Yr. Growth %	18.29	20.67	4.37	8.62	8.91
Earnings From Cont. Operations, 1 Yr. Growth %	20.54	27.22	-5.39	-5.88	5.49
Net Income, 1 Yr. Growth %	20.54	27.22	-5.22	-5.87	5.48
Normalized Net Income, 1 Yr. Growth %	20.17	20.71	0.46	3.81	-3.12
Diluted EPS Before Extra, 1 Yr. Growth %	20.73	26.12	-3.83	-7.96	-7.21
Accounts Receivable, 1 Yr. Growth %	34.12	3.89	15.14	37.22	10.01
Net Property, Plant and Equip., 1 Yr. Growth %	17.26	2.22	11.54	0.2	-1.02
Total Assets, 1 Yr. Growth %	29.12	11.88	3.74	54.75	-5.88
Tangible Book Value, 1 Yr. Growth %	-10.22	81.55	-6.64	137.12	-9.95
Common Equity, 1 Yr. Growth %	14.08	-0.59	-3.82	75.84	3.47
Cash From Operations, 1 Yr. Growth %	30.01	-13.5	57.53	-0.59	14.33
Capital Expenditures, 1 Yr. Growth %	48.03	-13.3	-6.75	3.95	31.01
Levered Free Cash Flow, 1 Yr. Growth %	24.31	7.45	40.44	-8.52	38.1
Unlevered Free Cash Flow, 1 Yr. Growth %	20.25	8.5	37.72	-1.48	39.04
Dividend Per Share, 1 Yr. Growth %	4.86	8.75	11.43	10.26	9.3
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.7	17.57	5.21	1.5	9.02
Gross Profit, 2 Yr. CAGR %	7.2	16.15	11.08	6.72	13.92
EBITDA, 2 Yr. CAGR %	9.47	19.69	12.33	6.67	15.79
EBITA, 2 Yr. CAGR %	10.31	20.35	12.94	6.82	16.16
EBIT, 2 Yr. CAGR %	11.54	19.48	12.23	6.48	8.77
Earnings From Cont. Operations, 2 Yr. CAGR %	42.73	23.84	9.71	-5.63	-0.36
Net Income, 2 Yr. CAGR %	42.73	23.84	9.81	-5.55	-0.36
Normalized Net Income, 2 Yr. CAGR %	17.93	20.44	10.12	4.8	0.29
Diluted EPS Before Extra, 2 Yr. CAGR %	43.09	23.4	10.23	-5.92	-7.59
Accounts Receivable, 2 Yr. CAGR %	21.41	18.04	9.37	25.7	22.87
Net Property, Plant and Equip., 2 Yr. CAGR %	50.88	9.48	6.78	5.72	-0.41
Total Assets, 2 Yr. CAGR %	7.01	20.19	7.74	26.71	20.69
Tangible Book Value, 2 Yr. CAGR %	-8.82	27.67	30.19	48.79	46.13
Common Equity, 2 Yr. CAGR %	8.65	6.49	-2.22	30.05	34.88
Cash From Operations, 2 Yr. CAGR %	10.36	6.05	16.73	25.14	6.61
Capital Expenditures, 2 Yr. CAGR %	30.14	13.29	-10.08	-1.55	16.7
Levered Free Cash Flow, 2 Yr. CAGR %	-5.17	15.57	22.84	13.35	12.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.17	14.22	22.24	16.48	17.04
Dividend Per Share, 2 Yr. CAGR %	6.83	6.79	9.54	10.84	9.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.54	11.23	13.5	2.54	7.93
Gross Profit, 3 Yr. CAGR %	6.39	10.63	12.21	10.29	10.78
EBITDA, 3 Yr. CAGR %	7.19	13.77	13.73	11.82	11.24
EBITA, 3 Yr. CAGR %	7.67	14.64	14.27	12.21	11.6
EBIT, 3 Yr. CAGR %	7.99	14.51	14.21	11.01	7.28
Earnings From Cont. Operations, 3 Yr. CAGR %	8.57	37.36	13.21	4.25	-2.06
Net Income, 3 Yr. CAGR %	8.57	37.36	13.28	4.31	-2.01
Normalized Net Income, 3 Yr. CAGR %	12.35	18.85	13.37	7.93	2.09
Diluted EPS Before Extra, 3 Yr. CAGR %	9.14	37.2	13.56	3.8	-6.35
Accounts Receivable, 3 Yr. CAGR %	16.71	15.26	17.06	17.96	20.23
Net Property, Plant and Equip., 3 Yr. CAGR %	28.87	32.52	10.16	4.54	3.42
Total Assets, 3 Yr. CAGR %	5.4	8.61	14.44	21.56	14.75
Tangible Book Value, 3 Yr. CAGR %	-5.58	14.71	15.02	58.99	25.86
Common Equity, 3 Yr. CAGR %	3.04	5.48	2.94	18.91	20.51
Cash From Operations, 3 Yr. CAGR %	11.26	1.75	21	10.65	21.43
Capital Expenditures, 3 Yr. CAGR %	9.29	13.66	6.17	-5.63	8.29
Levered Free Cash Flow, 3 Yr. CAGR %	33.23	-1.14	23.33	11.35	21.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	27.15	-1.52	21.57	13.76	23.56
Dividend Per Share, 3 Yr. CAGR %	9.94	7.46	8.15	9.78	10.33
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.58	9.71	9.54	7.23	11.69
Gross Profit, 5 Yr. CAGR %	6.79	8.49	8.24	9.05	12.9
EBITDA, 5 Yr. CAGR %	7.71	10.42	9.22	10.87	14.55
EBITA, 5 Yr. CAGR %	7.88	10.88	9.75	11.45	15.02
EBIT, 5 Yr. CAGR %	7.68	10.44	9.67	11.22	12
Earnings From Cont. Operations, 5 Yr. CAGR %	16.92	62.12	9.03	18.21	7.57
Net Income, 5 Yr. CAGR %	16.87	62.12	9.06	18.25	7.61
Normalized Net Income, 5 Yr. CAGR %	9.81	13.62	11.45	11.82	7.92
Diluted EPS Before Extra, 5 Yr. CAGR %	17.46	62.1	9.54	17.98	4.57
Accounts Receivable, 5 Yr. CAGR %	12.36	6.51	13.72	19.33	19.35
Net Property, Plant and Equip., 5 Yr. CAGR %	21.52	19.31	19.53	21.07	5.81
Total Assets, 5 Yr. CAGR %	8.67	7.29	6.33	15.52	16.9
Tangible Book Value, 5 Yr. CAGR %	8.9	12.51	7.37	27.29	26.58
Common Equity, 5 Yr. CAGR %	2.78	3.33	0.91	14.7	14.69
Cash From Operations, 5 Yr. CAGR %	11.48	6.89	13.42	10.53	15.02
Capital Expenditures, 5 Yr. CAGR %	7.17	4	1.09	7.32	10.26
Levered Free Cash Flow, 5 Yr. CAGR %	10.57	8.57	28.97	4.42	18.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.45	7.6	25.16	5.32	19.74
Dividend Per Share, 5 Yr. CAGR %	16.6	11.76	9.89	8.7	8.8